Health Insurance Innovations (HIIQ) Director Anthony Barkett Purchases 5,512 Shares of Stock

Health Insurance Innovations (NASDAQ:HIIQ) Director Anthony Barkett acquired 5,512 shares of the business’s stock in a transaction dated Tuesday, December 11th. The stock was purchased at an average cost of $6.40 per share, for a total transaction of $35,276.80. Following the transaction, the director now owns 6,512 shares in the company, valued at $41,676.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Anthony Barkett also recently made the following trade(s):

  • On Saturday, September 15th, Anthony Barkett acquired 13,574 shares of Health Insurance Innovations stock. The stock was purchased at an average cost of $22.00 per share, for a total transaction of $298,628.00.

HIIQ stock opened at $28.35 on Wednesday. The company has a market capitalization of $463.19, a P/E ratio of 20.25 and a beta of 0.41. Health Insurance Innovations has a 52 week low of $12.65 and a 52 week high of $37.38.

Health Insurance Innovations (NASDAQ:HIIQ) last released its earnings results on Wednesday, February 28th. The financial services provider reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.03. Health Insurance Innovations had a net margin of 7.14% and a return on equity of 21.27%. The company had revenue of $69.50 million during the quarter, compared to analysts’ expectations of $59.93 million. Health Insurance Innovations’s revenue for the quarter was up 35.2% compared to the same quarter last year. analysts anticipate that Health Insurance Innovations will post 1.95 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Lyon Street Capital LLC lifted its stake in Health Insurance Innovations by 55.2% during the 4th quarter. Lyon Street Capital LLC now owns 1,453,484 shares of the financial services provider’s stock valued at $36,264,000 after acquiring an additional 516,737 shares during the period. BlackRock Inc. lifted its stake in Health Insurance Innovations by 0.5% during the 4th quarter. BlackRock Inc. now owns 823,596 shares of the financial services provider’s stock valued at $20,548,000 after acquiring an additional 4,154 shares during the period. CAS Investment Partners LLC acquired a new stake in Health Insurance Innovations during the 4th quarter valued at approximately $18,717,000. Arrowstreet Capital Limited Partnership lifted its stake in Health Insurance Innovations by 131.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 668,208 shares of the financial services provider’s stock valued at $16,672,000 after acquiring an additional 379,308 shares during the period. Finally, Tenzing Global Management LLC lifted its stake in Health Insurance Innovations by 346.4% during the 4th quarter. Tenzing Global Management LLC now owns 312,500 shares of the financial services provider’s stock valued at $7,797,000 after acquiring an additional 242,500 shares during the period. Institutional investors and hedge funds own 79.36% of the company’s stock.

A number of research firms recently commented on HIIQ. ValuEngine cut shares of Health Insurance Innovations from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Canaccord Genuity reiterated a “buy” rating and issued a $55.00 target price (up from $39.00) on shares of Health Insurance Innovations in a research note on Friday, March 2nd. Lake Street Capital lifted their target price on shares of Health Insurance Innovations to $50.00 and gave the stock a “buy” rating in a research note on Thursday, March 1st. Craig Hallum reiterated a “buy” rating and issued a $45.00 target price (up from $38.00) on shares of Health Insurance Innovations in a research note on Thursday, March 1st. Finally, Raymond James upgraded shares of Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $34.60 target price for the company in a research note on Thursday, March 1st. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $42.62.

WARNING: This article was reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.chaffeybreeze.com/2018/04/25/health-insurance-innovations-hiiq-director-anthony-barkett-purchases-5512-shares-of-stock.html.

About Health Insurance Innovations

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply